Holen Sie sich die Stockscreener-App
2.2905
6.13%
-0.1495
Schlusskurs vom Vortag:
$2.44
Offen:
$2.42
24-Stunden-Volumen:
21,430
Relative Volume:
0.96
Marktkapitalisierung:
$16.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.65M
KGV:
-0.5147
EPS:
-4.45
Netto-Cashflow:
$-20.83M
1W Leistung:
+30.14%
1M Leistung:
+15.10%
6M Leistung:
+23.81%
1J Leistung:
-15.79%
1-Tages-Spanne:
$2.27
$2.42
1-Wochen-Bereich:
$1.76
$2.60
52-Wochen-Spanne:
$1.15
$3.00
Minerva Neurosciences Inc Stock (NERV) Company Profile
Firmenname
Minerva Neurosciences Inc
Sektor
Branche
Telefon
617-600-7373
Adresse
1601 TRAPELO ROAD, WALTHAM, MA
Vergleichen Sie NERV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
2.2905 | 15.74M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.76 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.28 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.78 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
656.89 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.51 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-10-02 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-09-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-09-18 | Eingeleitet | William Blair | Outperform |
| 2019-05-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-09-01 | Eingeleitet | Citigroup | Buy |
| 2017-03-06 | Fortgesetzt | Jefferies | Buy |
| 2016-05-12 | Fortgesetzt | Jefferies | Buy |
Alle ansehen
Minerva Neurosciences Inc Aktie (NERV) Neueste Nachrichten
How institutional ownership impacts Minerva Neurosciences Inc. stockJuly 2025 Trade Ideas & Verified Entry Point Detection - Newser
Key metrics from Minerva Neurosciences Inc.’s quarterly data2025 Dividend Review & Weekly Top Gainers Alerts - Newser
What earnings revisions data tells us about Minerva Neurosciences Inc.M&A Rumor & Verified Swing Trading Watchlists - Newser
What institutional flow reveals about Minerva Neurosciences Inc.Entry Point & Weekly High Potential Alerts - Newser
Evaluating Minerva Neurosciences Inc. with trendline analysisWeekly Trade Report & Detailed Earnings Play Strategies - Newser
Trend analysis for Minerva Neurosciences Inc. this weekQuarterly Profit Report & AI Driven Price Forecasts - Newser
Is Minerva Neurosciences Inc. building a consolidation baseFed Meeting & Daily Oversold Bounce Ideas - Newser
Can Minerva Neurosciences Inc. recover in the next quarterDay Trade & Technical Pattern Based Signals - Newser
Can volume confirm reversal in Minerva Neurosciences Inc.July 2025 Catalysts & Reliable Momentum Entry Alerts - Newser
What MACD and RSI say about Minerva Neurosciences Inc.Market Sentiment Summary & Accurate Buy Signal Alerts - Newser
Tools to assess Minerva Neurosciences Inc.’s risk profileMarket Performance Report & Technical Pattern Recognition Alerts - Newser
Why is Minerva Neurosciences Inc. stock going upMarket Risk Analysis & Advanced Technical Signal Analysis - mustnews.co.kr
Top chart patterns to watch in Minerva Neurosciences Inc.July 2025 Movers & Smart Allocation Stock Reports - Newser
What’s next for Minerva Neurosciences Inc. stock priceJuly 2025 Review & Capital Protection Trading Alerts - Newser
Is Minerva Neurosciences Inc. Stock a Smart Buy in 2025 Investment Analysis InsideEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
Is Minerva Neurosciences Inc. stock good for income investorsJuly 2025 Market Mood & Safe Capital Growth Trade Ideas - thegnnews.com
Is Minerva Neurosciences Inc. showing signs of accumulationTrade Risk Report & Safe Entry Trade Signal Reports - Newser
How cyclical is Minerva Neurosciences Inc.’s revenue streamJuly 2025 EndofMonth & Community Consensus Trade Signals - sundaytimes.kr
Using economic indicators to assess Minerva Neurosciences Inc. potentialGDP Growth & Weekly Top Gainers Trade List - Newser
Will Minerva Neurosciences Inc. outperform the market2025 Top Decliners & Entry Point Confirmation Alerts - Newser
Minerva Neurosciences Faces Regulatory Hurdle with FDA Mandated Trial for Roluperidone, Reports Q2 Loss and Low Cash Position - AInvest
What to expect from Minerva Neurosciences Inc. in the next 30 daysMarket Risk Analysis & Growth Focused Stock Reports - Newser
Minerva's 20% Surge: Earnings Spark Volatility Amid Biotech Sector Divergence - AInvest
Minerva Neurosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Why HUMAW stock attracts strong analyst attentionOil Prices & Capital Protection Trade Alerts - Newser
Minerva Neurosciences: Q2 Earnings Snapshot - Greenwich Time
P 500Earnings Performance Report & Fast Entry Momentum Trade Alerts - Newser
Minerva Neurosciences Reports Q2 2025 Financial Results - TipRanks
Volume Profile Shows Strong Base for Minerva Neurosciences Inc.July 2025 Movers & Risk Controlled Swing Alerts - sundaytimes.kr
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results - GlobeNewswire
FDA Demands New 52-Week Trial from Minerva as Cash Position Drops to $15.3M, Company Explores Sale - Stock Titan
What machine learning models say about Minerva Neurosciences Inc.July 2025 Trade Ideas & Real-Time Volume Trigger Notifications - Newser
Minerva Neurosciences Inc. stock daily chart insightsWeekly Trade Report & Verified Chart Pattern Signals - Newser
Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
3.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):